COMPASS Pathways plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CMPS Nasdaq 2836 compasspathways.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for COMPASS Pathways plc

Compass Pathways Elects Kathleen Tregoning to Board of Directors - May 28th, 2026 4:30 am
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026 - May 26th, 2026 4:30 am
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins - May 21st, 2026 12:03 am
This Psychedelics Stock Just Keeps Getting Hotter; Why Shares Bypassed A Profit-Taking Zone - May 18th, 2026 2:07 pm
Assessing COMPASS Pathways (CMPS) Valuation After Strong Q1 2026 Earnings And Key FDA Milestones - May 14th, 2026 9:15 pm
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026 - May 14th, 2026 4:30 am
Compass Pathways PLC (CMPS) Q1 2026 Earnings Call Highlights: Promising Advances in ... - May 13th, 2026 5:02 pm
Transcript: Compass Pathways Q1 2026 Earnings Conference Call - May 13th, 2026 4:34 pm
Here's Why This Psychedelics Stock Just Took A Trip To A Two-Year High - May 13th, 2026 2:08 pm
Compass (CMPS) Q1 2026 Earnings Transcript - May 13th, 2026 12:55 pm
Compass Pathways shares rise on Q1 results, accelerated FDA review - May 13th, 2026 10:33 am
Compass Pathways Q1 Earnings Call Highlights - May 13th, 2026 8:07 am
Compass Pathways jumps after earnings beat and accelerated FDA review progress (CMPS) - May 13th, 2026 6:54 am
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights - May 13th, 2026 4:30 am
Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026 - May 6th, 2026 4:30 am
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 6th, 2026 4:25 am
Neuronetics Q1 Earnings Call Highlights - May 5th, 2026 3:07 pm
Does FDA’s Rolling Review Of COMP360 Psilocybin Depression Therapy Change The Bull Case For COMPASS Pathways (CMPS)? - May 4th, 2026 12:11 pm
Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Airbnb, Alphabet, Check Point Software, GlobalFoundries, International Paper, Trade Desk, and More - May 4th, 2026 5:54 am
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Apr 28th, 2026 1:42 pm